What is Yissum?
Yissum operates as a specialized intermediary, facilitating the transition of intellectual property from the Hebrew University of Jerusalem into viable market ventures. By leveraging a robust portfolio of research, the company engages in high-stakes collaborations across the AgTech, pharmaceutical, and digital health sectors. Its business model is predicated on identifying high-potential academic breakthroughs and providing the necessary infrastructure to scale these technologies for industrial adoption. As a key player in the innovation ecosystem, Yissum effectively manages the lifecycle of research-based assets, ensuring that scientific advancements are translated into tangible economic value for both the university and its global industry partners.
How much funding has Yissum raised?
Yissum has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2013): $5M, investors not publicly disclosed
Key Investors in Yissum
Yissum
Undisclosed investor participating in the funding round.
What's next for Yissum?
Following this major enterprise-level funding, Yissum is positioned to accelerate its strategic initiatives in technology commercialization. The capital will likely be deployed to enhance the firm's capacity for venture creation and to deepen its engagement with international industry stakeholders. By focusing on high-growth verticals such as biotechnology and digital health, Yissum aims to expand its footprint in the global market, fostering a sustainable pipeline of research-driven enterprises. The organization's future trajectory will be defined by its ability to maintain its competitive edge in intellectual property management while scaling its collaborative efforts to meet the evolving demands of the global innovation landscape.
See full Yissum company page
